Metronomic chemotherapy in advanced oral cancers

Journal of Cancer Research and Therapeutics

Volumn 8, Issue SUPPL. 2, 2012, Pages

  Patil, Vijay ^a   Noronha, Vanita ^a   D'Cruz, A K ^a   Banavali, S D ^a   Prabhash, Kumar ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Chemotherapy; metronomic; oral cavity cancer; palliative

Indexed keywords

CELECOXIB; METHOTREXATE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PALLIATIVE THERAPY; PROGRESSION FREE SURVIVAL; RASH; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADMINISTRATION, METRONOMIC; ADOLESCENT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METHOTREXATE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PALLIATIVE CARE; PYRAZOLES; SULFONAMIDES;

EID: 84856911833     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.92223     Document Type: Article

References (19)

1. Mohanti BK, Umapathy H, Bahadur S, Thakar A, Pathy S. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol 2004;71:275-80. (Pubitemid 38686664)
2. Murthy V, Gupta T, Agarwal JP, Ghosh-Laskar S, Budrukkar A. Cautious optimism in advanced incurable head neck cancer. Radiother Oncol 2008;89:123-4.
3. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45:309-16.
4. Spector GJ. Distant metastases from laryngeal and hypopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:224-8. (Pubitemid 32620174)
5. Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001;111:1079-87. (Pubitemid 32523720)
6. Colevas AD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2006;24:2644-52. (Pubitemid 46628471)
7. Lamont EB, Vokes EE. Chemotherapy in the management of squamous-cell carcinoma of the head and neck. Lancet Oncol 2001;2:261-9. (Pubitemid 33591564)
8. Vermorken J, Hitt R, Geoffrois L, Erfan J, Kawecki A, Zabolotnyy D, et al. Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME). Eur J Cancer 2007;5:324.
9. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116-27.
10. Tejani MA, Cohen RB, Mehra R. The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer. Biologics 2010;4:173-85.
11. Rivera F, García-Castaño A, Vega N, Vega-Villegas ME, Gutiérrez-Sanz L. Cetuximab in metastatic or recurrent head and neck cancer: The EXTREME trial. Expert Rev Anticancer Ther 2009;9:1421-8.
12. Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 2005;23:8646-54. (Pubitemid 46211507)
13. Pasquier E, Kavallaris M, Andre N. Metronomic chemotherapy: New rationale for new directions. Nat Rev Clin Oncol 2010;7:455-65.
14. Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy. Semin Oncol 2004;31 (2 Suppl 7):2-11. (Pubitemid 38879409)
15. Pai RB, Lalitha RM, Pai SB, Kumaraswamy SV, Lalitha N, Bhargava MK. Analysis of in vitro and in vivo sensitivity of oral cancer cells to methotrexate. Exp Oncol 2009;31:118-20.
16. Glück S. Metronomic therapy in recurrent and metastatic chemoresistant SCCHN: Data from a pilot study. Proc Am Soc Clin Oncol 2003;22:A2066.
17. Agarwal JP, Nemade B, Murthy V, Ghosh-Laskar S, Budrukkar A, Gupta T, et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiother Oncol 2008;89:51-6.
18. Stevens CM, Huang SH, Fung S, Bayley AJ, Cho JB, Cummings BJ, et al. Retrospective study of palliative radiotherapy in newly diagnosed head and neck Carcinoma. Int J Radiat Oncol Biol Phys 2011;81:958-63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20950952 [Last cited on 2011 Jul 31].
19. Specenier PM, Vermorken JB. Recurrent head and neck cancer: Current treatment and future prospects. Expert Rev Anticancer Ther 2008;8:375-91. (Pubitemid 351836286)